Literature DB >> 10948982

Cross-protection and reassortment studies with avian H2 influenza viruses.

N V Kaverin1, Y A Smirnov, E A Govorkova, I A Rudneva, A K Gitelman, A S Lipatov, N L Varich, S S Yamnikova, N V Makarova, R G Webster, D K Lvov.   

Abstract

In order to assess the degree of immune cross-protection among avian H2 influenza virus strains, mice were immunised with beta-propiolactone-inactivated virus preparations and infected intranasally with mouse-adapted variant of A/Black Duck/New Jersey/1580/78 (H2N3) strain. The experiments with 11 avian H2 strains revealed that both Eurasian and American H2 avian influenza viruses exhibit either high or moderate degree of cross-protection. The grouping of the strains in accordance with their cross-protection efficiency does not coincide with H2 phylogenetic branches. Several reassortant clones were obtained with the use of A/Pintail Duck/Primorie/695/76 (H2N3) strain and high-yield X-67 reassortant as parent viruses, among them a high-yield H2N3 reassortant. Taking into account the data on cross-protection among avian H2 strains, the high-yield H2N3 reassortant may be regarded as a prototype strain to be used for the preparation of killed vaccines in the case of a new appearance of avian H2 haemagglutinin in circulation in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10948982     DOI: 10.1007/s007050070109

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets.

Authors:  Grace L Chen; Elaine W Lamirande; Chin-Fen Yang; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Vaccinate for the next H2N2 pandemic now.

Authors:  Gary J Nabel; Chih-Jen Wei; Julie E Ledgerwood
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

3.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

4.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

5.  Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013.

Authors:  Ahmed Kandeil; Rabeh El-Shesheny; Asmaa M Maatouq; Yassmin Moatasim; Mahmoud M Shehata; Ola Bagato; Adam Rubrum; Karthik Shanmuganatham; Richard J Webby; Mohamed Ahmed Ali; Ghazi Kayali
Journal:  Arch Virol       Date:  2014-07-03       Impact factor: 2.574

6.  Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.

Authors:  Grace L Chen; Elaine W Lamirande; Xing Cheng; Fernando Torres-Velez; Marlene Orandle; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

7.  Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses.

Authors:  Andrey Komissarov; Artem Fadeev; Anna Kosheleva; Kseniya Sintsova; Mikhail Grudinin
Journal:  Mol Cell Probes       Date:  2017-06-23       Impact factor: 2.365

8.  A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.

Authors:  Rui Xu; Jens C Krause; Ryan McBride; James C Paulson; James E Crowe; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2013-02-10       Impact factor: 15.369

9.  Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice.

Authors:  Mizuho Suzuki; Masatoshi Okamatsu; Takahiro Hiono; Keita Matsuno; Yoshihiro Sakoda
Journal:  J Vet Med Sci       Date:  2017-10-07       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.